Navigation Links
Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
Date:3/10/2009

EINDHOVEN, The Netherlands, March 10 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - the Dutch public-private partnership committed to the research and development of new techniques for the diagnosis and treatment of major diseases - today announced that eight new research projects will receive funding from the CTMM. It means that almost 250 million Euros have now been allocated to Netherlands-based translational projects that could radically improve patient outcomes for diseases such as Alzheimer's, rheumatoid arthritis, sepsis, cardiovascular disorders and the most important forms of cancer.

The eight new projects, each of which comprises a consortium of clinical and industrial partners, involve 13 leading university medical centers and research institutes, 29 expert SMEs (Small and Medium-sized Enterprises) and 15 major industrial players. 50% of the funding for these new projects is being contributed by the Dutch Government. The other 50% will come from industry and academia.

In line with the CTMM's original business plan, the newly approved projects include projects that target cancer, cardiovascular, neurodegenerative and infectious diseases. They also include projects to develop innovative new technology platforms, such as new medical imaging techniques, that can be applied across a broad spectrum of these diseases. The need for broad-based technology platforms in translational molecular medicine is underlined by the fact that all three technical universities that make up the Netherlands' 3TU.Federation (Delft, Eindhoven and Twente) are now involved in the CTMM.

Speaking on behalf of the 3TU.Federation, Amandus Lundqvist, President of the Technical University of Eindhoven (TU/e) said, "By applying our combined expertise in areas such as bio-nano applications, ICT systems and applied technology to CTMM projects, we believe we can help to boost the competitive
'/>"/>

SOURCE CTMM
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
3. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
4. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
7. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
8. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
9. SAFC Hitech(TM) Plans Further Expansion Into Asia
10. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
11. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 2015 , ... Global Resorcinol Market 2015-2019 is a comprehensive ... global resorcinol industry. The report highlights the various growth prospects and the prevalent ... of primary and secondary inputs from the existing players of the resorcinol market. ...
(Date:7/30/2015)... July 30, 2015   GenoSpace , a ... interpretation and analysis of genomic and other biomedical ... has joined the company as Vice President of ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners with ... interpret, analyze and explore complex sets of genomic, ...
(Date:7/30/2015)... 2015   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... its strategic partner VetStem Biopharma, Inc. has shared ... AT-016, an adipose-derived allogeneic stem cell product exclusively ... pain in dogs. The double-blinded, multi-site, ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, Inc. ... has received the second $1.0M tranche under a ... (SBIR) grant valued at up to $3.0 million ... KL4 surfactant as a potential medical countermeasure to ... Labs was awarded an initial $1.0 million under ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... ... ... -- Professor Jean M. J. Frchet, a pioneering chemist who has achieved great success ... King Abdullah University of Science and Technology (KAUST) in Saudi Arabia., , , , ...
... ... American Communications Professionals Honors LaVoie Group for Best Industry-Exclusive Agency and Best Business ... ... Group , a life science and pharmaceuticals focused strategic communications agency, announced today ...
... , ... a life science-focused strategic communications agency, announced today that it has been selected by ... develop and execute its corporate communications and public relations program. , ... Salem, MA (Vocus) February 8, 2010 ...
Cached Biology Technology:Frchet Named Vice President for Research at Kaust 2Frchet Named Vice President for Research at Kaust 3Frchet Named Vice President for Research at Kaust 4Frchet Named Vice President for Research at Kaust 5LaVoie Group Honored by LACP with Two Awards 2LaVoie Group Honored by LACP with Two Awards 3LaVoie Group Honored by LACP with Two Awards 4Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the fourth quarter and ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-455-2260 ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... release is available in German . ... strategy for the individual but it can drive the species ... Daniel Rankin from the University of Zurich has demonstrated in ... long debated whether the behavior of the individual is able ...
... Monday, May 16, 2011 A new discovery in mice ... day allow doctors to spare some patients with acute myeloid ... for new therapeutic research. AML, the most common ... form of cancer that primarily affects the elderly. Despite years ...
... Packard and the University of California, Santa Barbara, have ... of an electronic device that computer engineers hope will ... memory resistors, are a newly understood circuit element for ... seek ways of mimicking the behaviour of our own ...
Cached Biology News:Aggressive male mating behavior can endanger species 2Study reveals need for personalized approach in treatment of AML 2Study reveals need for personalized approach in treatment of AML 3'Computer synapse' analyzed at the nanoscale 2